Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Aristo Bio-Tech and Lifescience (NSE:ARISTO) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Aristo Bio-Tech and Lifescience's EV-to-EBIT for today is
Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹855 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹75 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Aristo Bio-Tech and Lifescience's EV-to-EBITDA for today is:
Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹855 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₹101 Mil.
Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹855 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₹3,181 Mil.
Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹855 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹100 Mil.
Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹855 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ₹49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience Enterprise Value Related Terms
Aristo Bio-Tech and Lifescience Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience Enterprise Value Chart
NSE:ARISTO vs CTVA, CF: Enterprise Value Comparison
For the Agricultural Inputs subindustry, Aristo Bio-Tech and Lifescience's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aristo Bio-Tech and Lifescience Enterprise Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Aristo Bio-Tech and Lifescience's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Aristo Bio-Tech and Lifescience's Enterprise Value falls into.
Aristo Bio-Tech and Lifescience Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a Enterprise Value of ₹855 Mil as of Jul. 11, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's Enterprise Value too high?
Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹855 Mil. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's Enterprise Value compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's Enterprise Value of ₹855 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Agriculture company?
A good Enterprise Value depends on the Agriculture industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Aristo Bio-Tech and Lifescience and its competitors. Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹855 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current Enterprise Value of ₹855 Mil. The current Enterprise Value is ₹855 Mil. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current Enterprise Value is ₹855 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aristo Bio-Tech and Lifescience Business Description
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score
Get the complete analysis for NSE:ARISTO
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ARISTO has been successfully added to your 
